Back to Journals » OncoTargets and Therapy » Volume 13
Corrigendum
Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,345 | Dovepress* | 3,160+ | 624 | 3,784 | |
PubMed Central* | 185 | 58 | 243 | ||
Totals | 3,345 | 682 | 4,027 | ||
*Since 4 September 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar